Pontificia Universidad Catolica de Chile
2 clinical trials · 2 recruiting · OTHER
Trials by Pontificia Universidad Catolica de Chile
RECRUITINGNCT06758024
PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
Infliximab (IFX) is a Food and Drug administration (FDA)-appoved monoclonal antibody medication targeting tumor necrosis factor (TNF) widely used in inflammatory bowel disease...
Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 721 location
Inflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)
RECRUITINGNCT07086820
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
The goal of this cluster-randomized controlled trial is to evaluate the effectiveness of tuberculosis preventive treatment (TPT) administered during the "window period" to prevent...
Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 64713 locations
Tuberculosis InfectionHousehold ContactsChildren+3